NAPLEX Flashcards: Monitoring Parameters Labs And Vitals

What this deck covers

This deck focuses on Monitoring Parameters Labs And Vitals, giving you a quick way to review the definitions, rules, and examples that matter most for NAPLEX.

How to use these flashcards

Work through these flashcards in short sessions. Try to answer each prompt before flipping the card, then revisit any cards you miss until the explanation feels automatic.

Flashcard 1: Which laboratory parameter is the primary monitor for digoxin toxicity risk in renal impairment?

Answer: Serum digoxin concentration (plus renal function and potassium). Monitors drug accumulation in renal impairment, with hypokalemia exacerbating toxicity risks.

Flashcard 2: Which two labs should be monitored after starting spironolactone for heart failure?

Answer: Serum potassium and serum creatinine. Spironolactone's aldosterone antagonism can cause hyperkalemia and worsen renal function in heart failure patients.

Flashcard 3: Which laboratory parameter must be monitored with metformin due to rare but serious toxicity risk?

Answer: Renal function (serum creatinine or eGFR). Assesses kidney function to prevent metformin accumulation and risk of lactic acidosis in impaired clearance.

Flashcard 4: Which laboratory parameter is required to monitor for statin-associated hepatotoxicity when indicated?

Answer: ALT (liver transaminases). Elevations in transaminases indicate potential liver injury, prompting evaluation in symptomatic patients or per guidelines.

Flashcard 5: Which vital sign should be monitored to detect orthostatic hypotension from alpha-1 blockers?

Answer: Blood pressure (including orthostatic measurements). Alpha-1 blockade causes vasodilation, potentially leading to postural blood pressure drops requiring monitoring.

Flashcard 6: Which laboratory test monitors for clozapine-induced agranulocytosis risk?

Answer: Absolute neutrophil count (ANC). Weekly monitoring detects severe neutropenia early, preventing infections from clozapine's agranulocytosis risk.

Flashcard 7: Which lab must be monitored with methotrexate therapy to detect myelosuppression?

Answer: CBC (white blood cells, hemoglobin, platelets). Detects reductions in blood cell lines indicating bone marrow suppression, a dose-limiting toxicity of methotrexate.

Flashcard 8: Which daily self-monitoring parameter best detects hypoglycemia risk with insulin or sulfonylureas?

Answer: Capillary blood glucose (SMBG). Enables real-time detection of low blood sugar to prevent hypoglycemic episodes in patients on these agents.

Flashcard 9: What is the preferred pharmacokinetic exposure target for vancomycin in serious MRSA infections?

Answer: AUC/MIC $400$ to $600$ (assume MIC $= 1$). Optimizes efficacy against MRSA while reducing risks of resistance and toxicity based on pharmacokinetic guidelines.

Flashcard 10: Which electrolyte must be monitored closely with ACE inhibitors due to hyperkalemia risk?

Answer: Serum potassium. ACE inhibitors reduce aldosterone, promoting potassium retention and increasing hyperkalemia risk, especially in renal impairment.

Flashcard 11: Which aminoglycoside toxicity is most associated with rising serum creatinine during therapy?

Answer: Nephrotoxicity. Rising creatinine indicates renal tubular damage from aminoglycoside accumulation, a common dose-related toxicity.

Flashcard 12: Which laboratory parameter is the standard efficacy monitor for diabetes therapy over 3 months?

Answer: Hemoglobin A1c. Provides an average measure of glycemic control over 2-3 months to evaluate long-term diabetes management efficacy.

Flashcard 13: What laboratory test is used to monitor warfarin anticoagulation intensity?

Answer: INR. Standardizes prothrombin time to evaluate vitamin K antagonist effects and guide dosing for optimal anticoagulation.

Flashcard 14: Which vital sign is the primary monitoring parameter for beta-blocker dose titration?

Answer: Heart rate (and blood pressure). Assesses beta-adrenergic blockade to titrate doses for heart rate reduction and blood pressure control.

Flashcard 15: Which laboratory parameter is required to monitor lithium therapy for efficacy and toxicity?

Answer: Serum lithium concentration. Maintains levels within the therapeutic range to ensure mood stabilization while avoiding neurotoxicity.

Flashcard 16: Which lab should be monitored with SGLT2 inhibitors to assess renal eligibility and ongoing safety?

Answer: eGFR (renal function). Determines treatment eligibility and monitors for renal adverse effects, as SGLT2 inhibitors affect kidney function.

Flashcard 17: Which laboratory parameter is the primary monitor for thyroid hormone replacement dose adjustment?

Answer: TSH (and free $T_4$ in selected situations). TSH levels guide levothyroxine dosing to achieve euthyroid state, with free T4 used in specific clinical scenarios.

Flashcard 18: Which lab value should be monitored to assess bleeding risk and marrow suppression with linezolid?

Answer: Platelet count (CBC). Detects thrombocytopenia from myelosuppression, which increases bleeding risk during prolonged therapy.

Flashcard 19: Which lab is used to evaluate statin-associated muscle injury when symptoms occur?

Answer: Creatine kinase (CK). Elevated levels confirm muscle damage in symptomatic patients, guiding management of statin-induced myopathy.

Flashcard 20: Which two additional labs should be monitored during chronic lithium therapy beyond drug level?

Answer: TSH and serum creatinine (renal function). Lithium can induce hypothyroidism and renal impairment, necessitating periodic screening for these long-term effects.

Flashcard 21: Which laboratory parameter is most important to monitor for aminoglycoside nephrotoxicity?

Answer: Serum creatinine (renal function). Reflects glomerular filtration rate changes to detect early nephrotoxic effects from aminoglycoside exposure.

Flashcard 22: Which laboratory parameter is the primary safety monitor for unfractionated heparin infusion?

Answer: aPTT (or anti-Xa per institutional protocol). Measures coagulation time to ensure therapeutic anticoagulation and minimize bleeding risk during continuous infusion.

Flashcard 23: Which laboratory parameter is used to monitor valproic acid exposure for seizure control?

Answer: Serum valproic acid concentration. Ensures therapeutic levels for anticonvulsant efficacy while minimizing risks of toxicity in epilepsy management.

Flashcard 24: Which two parameters are essential to monitor for vancomycin nephrotoxicity and exposure?

Answer: Serum creatinine and vancomycin AUC (or trough per protocol). Tracks renal function for nephrotoxicity detection and drug exposure for efficacy and safety optimization.

Flashcard 25: Which laboratory parameter is preferred for monitoring low-molecular-weight heparin when needed?

Answer: Anti-Xa level (LMWH-calibrated). Directly assesses anticoagulant activity for dose adjustment in patients requiring monitoring, such as those with renal impairment or obesity.